Last 12 months
Inside the activity.
1 purchase rows · 44 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2024 Filed Mar 15, 2024 20:12 UTC |
Boughton SoleilChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 63,621 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000059 · wk-form4_1710533549.xml · derivative · entry 3 Boughton Soleil · CIK 0001837817 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,769 Underlying: Class A Common Stock · 63,621 shares Expires 2030-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2023 by the Reporting Person. F3 · derivative.exercise_date: The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous service beginning February 12, 2020. 100% of the shares subject to the option have vested. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:12 UTC |
Boughton SoleilChief Legal Officer
|
SaleClass A Common Stock | 63,621 | $15.17 | $965,016.05 |
DisclosureSEC source: 0001773751-24-000059 · wk-form4_1710533549.xml · nonDerivative · entry 2 Boughton Soleil · CIK 0001837817 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,345 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.00 - $15.375. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:12 UTC |
Boughton SoleilChief Legal Officer
|
Exercise / conversionClass A Common Stock | 63,621 | $2.43 | $154,599.03 |
DisclosureSEC source: 0001773751-24-000059 · wk-form4_1710533549.xml · nonDerivative · entry 1 Boughton Soleil · CIK 0001837817 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,966 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 8, 2023 by the Reporting Person. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,036 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 18 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 775,411 Underlying: Class A Common Stock · 5,036 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,715 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 17 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 780,447 Underlying: Class A Common Stock · 6,715 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
SaleClass A Common Stock | 5,036 | $14.35 | $72,270.13 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 12 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 507,465 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.08 - $14.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
SaleClass A Common Stock | 6,715 | $14.36 | $96,413.97 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.13- $14.66. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionClass A Common Stock | 6,715 | $0.40 | $2,686.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionClass A Common Stock | 5,036 | $0.40 | $2,014.40 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 01:10 UTC | SaleClass A Common Stock | 2,747 | $14.19 | $38,979.93 |
DisclosureSEC source: 0001773751-24-000056 · wk-form4_1709860216.xml · nonDerivative · entry 1 Becklund Irene · CIK 0001894602 · PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2023 by the Reporting Person. Read SEC document |
|
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,715 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 16 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 787,162 Underlying: Class A Common Stock · 6,715 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,036 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 15 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 793,877 Underlying: Class A Common Stock · 5,036 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
SaleClass A Common Stock | 6,715 | $13.99 | $93,915.99 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 507,465 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.72 - $14.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
SaleClass A Common Stock | 5,036 | $13.99 | $70,444.07 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 514,180 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.55- $14.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionClass A Common Stock | 6,715 | $0.40 | $2,686.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionClass A Common Stock | 5,036 | $0.40 | $2,014.40 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,036 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 14 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 798,913 Underlying: Class A Common Stock · 5,036 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,715 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 13 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 803,949 Underlying: Class A Common Stock · 6,715 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
SaleClass A Common Stock | 5,036 | $14.22 | $71,603.36 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 507,465 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.99 - $14.475. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
SaleClass A Common Stock | 6,715 | $14.22 | $95,459.10 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.96 - $14.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionClass A Common Stock | 5,036 | $0.40 | $2,014.40 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC |
Baird MelissaChief Operating Officer
|
Exercise / conversionClass A Common Stock | 6,715 | $0.40 | $2,686.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 514,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 01:10 UTC | GrantRestricted Stock Unit · Derivative | 69,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000056 · wk-form4_1709860216.xml · derivative · entry 2 Becklund Irene · CIK 0001894602 · PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,518 Underlying: Class A Common Stock · 69,518 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
|
| March 04, 2024 Filed Mar 5, 2024 21:39 UTC | Exercise / conversionStock Option (right to buy) · Derivative | 17,930 | $0.00 Strike: $9.41 | $0.00 |
DisclosureSEC source: 0001773751-24-000051 · wk-form4_1709674751.xml · derivative · entry 4 Becklund Irene · CIK 0001894602 · PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,718 Underlying: Class A Common Stock · 17,930 shares Expires 2030-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2023 by the Reporting Person. F2 · derivative.exercise_date: The shares of Class A common stock subject to the stock option vest in a series of forty-eight successive equal monthly installments beginning on February 16, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document |
|
| March 04, 2024 Filed Mar 5, 2024 21:39 UTC | SaleClass A Common Stock | 17,930 | $14.50 | $259,985.00 |
DisclosureSEC source: 0001773751-24-000051 · wk-form4_1709674751.xml · nonDerivative · entry 3 Becklund Irene · CIK 0001894602 · PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,747 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2023 by the Reporting Person. Read SEC document |
|
| March 04, 2024 Filed Mar 5, 2024 21:39 UTC | Exercise / conversionClass A Common Stock | 17,930 | $9.41 | $168,721.30 |
DisclosureSEC source: 0001773751-24-000051 · wk-form4_1709674751.xml · nonDerivative · entry 2 Becklund Irene · CIK 0001894602 · PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2023 by the Reporting Person. Read SEC document |
|
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC |
Okupe OluyemiChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,527 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 964,395 Underlying: Class A Common Stock · 40,527 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F5 · derivative.exercise_date: 25% of the options vested on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service with the Issuer. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC |
Okupe OluyemiChief Financial Officer
|
SaleClass A Common Stock | 43,876 | $13.57 | $595,498.23 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,674 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.34 - $13.725. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC |
Okupe OluyemiChief Financial Officer
|
SaleClass A Common Stock | 3,349 | $13.41 | $44,900.04 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,550 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.35 - $13.51. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC |
Okupe OluyemiChief Financial Officer
|
SaleClass A Common Stock | 3,349 | $13.40 | $44,889.33 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,899 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.35 - $13.50. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:41 UTC |
Okupe OluyemiChief Financial Officer
|
Exercise / conversionClass A Common Stock | 40,527 | $5.01 | $203,040.27 |
DisclosureSEC source: 0001773751-24-000053 · wk-form4_1709674881.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:43 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 188,896 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · derivative · entry 13 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,715,120 Underlying: Class A Common Stock · 188,896 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:43 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
SaleClass A Common Stock | 144,448 | $13.07 | $1,888,022.03 |
DisclosureSEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 1,599,310 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.73 - $13.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:43 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
SaleClass A Common Stock | 240,549 | $13.07 | $3,144,119.76 |
DisclosureSEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.73 - $13.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:43 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionClass A Common Stock | 188,896 | $2.43 | $459,017.28 |
DisclosureSEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:39 UTC | SaleClass A Common Stock | 2,747 | $13.16 | $36,150.52 |
DisclosureSEC source: 0001773751-24-000051 · wk-form4_1709674751.xml · nonDerivative · entry 1 Becklund Irene · CIK 0001894602 · PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,747 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2023 by the Reporting Person. Read SEC document |
|
| February 29, 2024 Filed Mar 1, 2024 21:06 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 577,007 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · derivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,904,016 Underlying: Class A Common Stock · 577,007 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:06 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
SaleClass A Common Stock | 577,007 | $12.96 | $7,480,261.05 |
DisclosureSEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,653 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:06 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionClass A Common Stock | 577,007 | $2.43 | $1,402,127.01 |
DisclosureSEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 628,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 16:07 UTC |
Baird MelissaChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 418,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000044 · wk-form4_1709327211.xml · derivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,141 Underlying: Class A Common Stock · 418,141 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
WELLS DAVID BDirector
|
SaleClass A Common Stock | 260,000 | $13.16 | $3,421,210.00 |
DisclosureSEC source: 0001773751-24-000040 · wk-form4_1709327135.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,195 F1 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.15 - $13.2201. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:07 UTC |
Carroll Patrick HarrisonDirector · Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 77,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000046 · wk-form4_1709327251.xml · derivative · entry 2 Carroll Patrick Harrison · CIK 0001839736 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,433 Underlying: Class A Common Stock · 77,433 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:07 UTC |
Carroll Patrick HarrisonDirector · Chief Medical Officer
|
SaleClass A Common Stock | 20,000 | $13.19 | $263,800.00 |
DisclosureSEC source: 0001773751-24-000046 · wk-form4_1709327251.xml · nonDerivative · entry 1 Carroll Patrick Harrison · CIK 0001839736 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,835 Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:07 UTC |
Okupe OluyemiChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 367,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000045 · wk-form4_1709327237.xml · derivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,809 Underlying: Class A Common Stock · 367,809 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:06 UTC |
Chi MichaelChief Marketing Officer
|
GrantRestricted Stock Unit · Derivative | 309,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000043 · wk-form4_1709327191.xml · derivative · entry 2 Chi Michael · CIK 0001965903 · Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,734 Underlying: Class A Common Stock · 309,734 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:06 UTC |
Chi MichaelChief Marketing Officer
|
SaleClass A Common Stock | 47,687 | $13.19 | $628,991.53 |
DisclosureSEC source: 0001773751-24-000043 · wk-form4_1709327191.xml · nonDerivative · entry 1 Chi Michael · CIK 0001965903 · Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,089 Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:06 UTC |
Boughton SoleilChief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 193,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000042 · wk-form4_1709327171.xml · derivative · entry 1 Boughton Soleil · CIK 0001837817 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,584 Underlying: Class A Common Stock · 193,584 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:06 UTC |
Dudum AndrewDirector · Chief Executive Officer · 10% owner
|
GrantRestricted Stock Unit · Derivative | 1,192,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · derivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,192,477 Underlying: Class A Common Stock · 1,192,477 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 21:33 UTC | SaleClass A Common Stock | 2,747 | $12.08 | $33,183.76 |
DisclosureSEC source: 0001773751-24-000032 · wk-form4_1709155970.xml · nonDerivative · entry 1 Becklund Irene · CIK 0001894602 · PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,494 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2023 by the Reporting Person. Read SEC document |
|
| February 15, 2024 Filed Feb 16, 2024 21:47 UTC |
Boughton SoleilChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,972 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000014 · wk-form4_1708120066.xml · derivative · entry 6 Boughton Soleil · CIK 0001837817 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,390 Underlying: Class A Common Stock · 5,972 shares Expires 2030-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous Service beginning February 12, 2020. 100% of the shares subject to the option award are fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.